---
schema_version: "secwatch.filing_event.v1"
accession: "0001841387-26-000009"
form_type: "8-K"
ticker: "CADL"
cik: "0001841387"
company_name: "Candel Therapeutics, Inc."
filed_at: "2026-06-24T20:24:12+00:00"
generated_at: "2026-06-24T20:25:15.436592+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Candel shareholders elect four Class II directors, ratify KPMG as auditor at June 23 annual meeting

## Summary
- Elected Edward J. Benz, Paul B. Manning, Maha Radhakrishnan, and Paul Peter Tak as Class II directors for three-year terms.
- Director voting: Benz received 24.9M for, 6.8M withheld; Manning 31.6M for, 102k withheld; Radhakrishnan 31.0M for, 646k withheld; Tak 31.4M for, 279k withheld.
- KPMG LLP ratified as independent auditor for FY 2026 with 53.5M for, 238k against, 88k abstain.
- All proposals passed; no other matters were voted on at the meeting.

## SEC filing metadata
- accession: 0001841387-26-000009
- form_type: 8-K
- ticker: CADL
- cik: 0001841387
- company_name: Candel Therapeutics, Inc.
- filed_at: 2026-06-24T20:24:12+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841387/000184138726000009/0001841387-26-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841387/000184138726000009/cadl-20260623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001841387-26-000009
- JSON: https://secwatch.observer/filing/0001841387-26-000009.json
- Plain text: https://secwatch.observer/filing/0001841387-26-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.